A clinical evaluation of pivampicillin in childhood pneumonia.
A clinical trial was done at the University Teaching (Children's) Hospital on 20 children suffering from clinical pneumonias with a specific drug regime with pivampicillin suspension. Every child was reexamined after 7-10 days of discharge from hospital. Only one chhild developed diarrhoea. There was no significant adverse drug toxicity shown in the biomedical investigations. Pivampicillin, three times a day at a dosage of 175 mg t.d.s. was found to be therapeutically effective in the treatment of childhood pneumonias.
D000667:Ampicillin / Q000031:analogs & derivatives*; D000818:Animals; D002648:Child; D002675:Child, Preschool; D004285:Dogs; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010917:Pivampicillin / Q000008:administration & dosage / Q000627:therapeutic use*; D011014:Pneumonia / Q000188:drug therapy*; D051381:Rats
D010917:Pivampicillin; D000667:Ampicillin